Innate Pharma(IPHA) - 2025 Q4 - Earnings Call Transcript

Innate Pharma (NasdaqGS:IPHA) Q4 2025 Earnings call March 26, 2026 09:00 AM ET Company ParticipantsChristopher Liu - Managing DirectorFrédéric Lombard - CFOJonathan Dickinson - CEOSonia Quaratino - CMOStéphanie Cornen - VP of Investor Relations, Communications, and Commercial StrategyYannis Morel - COOConference Call ParticipantsDaina Graybosch - Senior Research AnalystJeet Mukherjee - VP and Biotechnology AnalystSwayampakula Ramakanth - Managing Director of Equity Research and Senior Healthcare AnalystOper ...